发明名称 Integrated delivery device for continuous glucose sensor
摘要 Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.
申请公布号 US8920401(B2) 申请公布日期 2014.12.30
申请号 US201213460337 申请日期 2012.04.30
申请人 DexCom, Inc. 发明人 Brauker James H.;Tapsak Mark A.;Saint Sean T.;Kamath Apurv U.;Neale Paul V.;Simpson Peter C.;Mensinger Michael Robert;Markovic Dubravka
分类号 A61M31/00;A61B5/145;A61B5/00;G06F19/00;A61M5/315;A61B5/1486 主分类号 A61M31/00
代理机构 Knobbe Martens Olson & Bear LLP 代理人 Knobbe Martens Olson & Bear LLP
主权项 1. An integrated diabetes management system for selectively switching between automated and fail-safe modes, the system comprising: a glucose sensor, wherein the glucose sensor is configured to substantially continuously measure glucose concentration in a host for a period exceeding one hour, and to output a data stream, including one or more sensor data points; and a processor module operably connected to the glucose sensor, wherein the processor module is configured to receive the data stream, to calculate a therapy comprising instructions for administration of a medicament, and to send the instructions to a medicament delivery device, wherein the processor module is configured to operate the integrated system in an automated mode unless a fail-safe mode is triggered, wherein the automated mode does not require user interaction to send the instructions to the medicament delivery device, wherein in the fail-safe mode, the processor module is configured to prompt the host for input before sending the instructions to the medicament delivery device, and wherein the fail-safe mode is automatically triggered responsive to a predetermined fail-safe condition.
地址 San Diego CA US